Cardiac

  • A view of Boston Scientific's corporate headquarters in Marlborough, Massachusetts, with a clear blue sky in the background.
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    Boston Scientific study meets goals for PFA in persistent AFib

    The results will support the company’s application for expanded labeling of its popular Farapulse pulsed field ablation system in a larger group of patients with atrial fibrillation.

    By • Jan. 21, 2025
  • San Francisco Golden Gate
    Image attribution tooltip
    Jason Doiy / Getty Images via Getty Images
    Image attribution tooltip

    JPM25 recap: Robotics, PFA and OTC glucose sensors in the spotlight

    CEOs from Medtronic, Intuitive Surgical, Boston Scientific and Dexcom were on hand this week in San Francisco to discuss the year ahead at the J.P. Morgan Healthcare Conference.

    By • Jan. 17, 2025
  • Front sign of FDA building Explore the Trendline➔
    Image attribution tooltip
    Sarah Silbiger via Getty Images
    Image attribution tooltip
    Trendline

    Medical device safety in spotlight after high profile recalls

    From Philips’ massive recall of respiratory devices to ongoing health risks with breast implants, medical devices tied to patient harm have put a focus on product safety.

    By MedTech Dive staff
  • Boston Scientific's Farapulse pulsed field ablation device.
    Image attribution tooltip
    Permission granted by Boston Scientific
    Image attribution tooltip

    Boston Scientific ups PFA forecast, targets market leadership

    At the J.P. Morgan Healthcare Conference, Boston Scientific forecast that pulsed field ablation will be used in more than 60% of atrial fibrillation procedures globally by 2026.

    By • Jan. 15, 2025
  • Image attribution tooltip
    Patrik Stollarz / Staff via Getty Images
    Image attribution tooltip

    Philips recall of heart monitor software tied to 109 injuries, 2 deaths

    Some electrocardiogram events, such as atrial fibrillation or abnormally rapid heartbeats, over two years were not reviewed by healthcare professionals due to a data routing issue.

    By • Jan. 14, 2025
  • Medtronic's Affera all-in-one ablation system
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    CEO Geoff Martha tells JPM crowd Medtronic is ‘stacking growth drivers’

    New technologies for atrial fibrillation, hypertension, diabetes and neurological conditions are poised for fast growth, Martha said Monday at the J.P. Morgan Healthcare Conference.

    By • Jan. 14, 2025
  • Rendering of a spiral-shaped catheter with four electrodes
    Image attribution tooltip
    Permission granted by Medtronic
    Image attribution tooltip

    CMS starts Medicare coverage analysis for Medtronic, Recor renal denervation devices

    J.P. Morgan analysts said the CMS’ review “validates the technology and could potentially move the needle on growth for Medtronic.”

    By • Jan. 14, 2025
  • Justin Spencer, new Eko Health CFO, wears a gray suit jacket and light blue shirt.
    Image attribution tooltip
    Courtesy of Eko Health
    Image attribution tooltip

    Eko Health names Justin Spencer as CFO

    Spencer’s arrival at Eko comes months after the digital health company appointed his former colleague Brent Lang to its board of directors.

    By • Jan. 10, 2025
  • A picture of a person in a dark yellow seater holding their smartphone and looking at their health data.
    Image attribution tooltip
    Retrieved from Fire1 on January 10, 2025
    Image attribution tooltip

    Fire1 raises $120M to trial heart failure management system

    Medtronic and Novo Holdings were among the investors in the funding round.

    By • Jan. 10, 2025
  • Intuitive Surgical's da Vinci 5 robotic system.
    Image attribution tooltip
    Courtesy of Intuitive Surgical
    Image attribution tooltip
    Deep Dive // 2025 outlook

    5 medtech trends to watch in 2025

    After a busy 2024, experts called out competition in soft tissue robotics, uncertainty from a Trump White House and continued success for pulsed field ablation as trends to watch this year.

    By • Jan. 9, 2025
  • A photo of Johnson & Johnson's pulsed field ablation system for atrial fibrillation.
    Image attribution tooltip
    Courtesy of Johnson & Johnson
    Image attribution tooltip

    J&J pauses Varipulse PFA cases in US

    The temporary halt to investigate reported neurovascular events comes two months after Johnson & Johnson won FDA approval for the pulsed field ablation system.

    By • Jan. 8, 2025
  • A view of Boston Scientific's corporate headquarters in Marlborough, Massachusetts, with a clear blue sky in the background.
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    Boston Scientific to buy remaining Bolt Medical stake for up to $664M

    The deal for Bolt, developer of an intravascular lithotripsy system to treat coronary and peripheral artery disease, continues Boston Scientific’s brisk run of acquisitions.

    By • Jan. 8, 2025
  • An exterior shot of the johnson and johnson logo in red outside the company's headquarters
    Image attribution tooltip
    Mario Tama / Staff via Getty Images
    Image attribution tooltip

    Top 10 medtech deals of 2024

    Multibillion-dollar buyouts returned last year, led by Johnson & Johnson’s $13.1 billion acquisition of Shockwave Medical.

    By • Jan. 2, 2025
  • A circular device with a metal mesh around it.
    Image attribution tooltip
    Courtesy of Edwards Lifesciences
    Image attribution tooltip

    CMS proposes Medicare coverage for transcatheter tricuspid replacement

    Edwards submitted a request for a national coverage determination in February, after receiving FDA approval for its Evoque device earlier that month.

    By • Updated Dec. 23, 2024
  • CMR Surgical Co-founder and CMO Mark Slack stands with his arms crossed in front of a Versius robot.
    Image attribution tooltip
    Permission granted by CMR Surgical
    Image attribution tooltip

    Robots, AI and PFA: The top medtech Q&As of 2024

    From challenging market leaders to the growing influence of artificial intelligence, medical device executives had a lot to discuss this year. Check out MedTech Dive’s top Q&As of 2024.

    By • Dec. 20, 2024
  • A stethoscope rests on a pile of $100 bills.
    Image attribution tooltip
    Foremniakowski via Getty Images
    Image attribution tooltip

    Heart valve developer Anteris launches IPO

    IPOs in medtech have been sparse, but some analysts said improving market conditions could support a revival of offerings in 2025.

    By • Dec. 20, 2024
  • A view of Boston Scientific's corporate headquarters in Marlborough, Massachusetts, with a clear blue sky in the background.
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    Boston Scientific updates cryoablation catheter instructions after 4 death reports

    The update followed a higher than expected number of reports of esophageal injury after catheter ablation procedures for atrial fibrillation.

    By • Dec. 19, 2024
  • Merit Medical President Joseph Wright wears a light blue shirt, gray jacket and glasses in a headshot.
    Image attribution tooltip
    Retrieved from Merit Medical on December 17, 2024
    Image attribution tooltip

    Merit Medical president to resign after unspecified conduct allegations

    Joseph Wright’s resignation is effective in January, and CEO and founder Fred Lampropoulos has been reappointed president.

    By • Dec. 18, 2024
  • Medtronic's Affera all-in-one ablation system
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    PFA to surpass radiofrequency ablation in 2025: Citi survey

    Pulsed field ablation could soon be used in the majority of electrophysiology procedures to treat atrial fibrillation as Medtronic, Boston Scientific and Johnson & Johnson battle for market share.

    By • Dec. 16, 2024
  • Capstan employee Evelyn Haynes is wearing blue gloves while working on the company's heart valve device.
    Image attribution tooltip
    Permission granted by Capstan Medical
    Image attribution tooltip

    Capstan Medical raises $110M for heart valve with robotic system

    The startup’s third round of financing includes support from Intuitive Surgical’s venture capital arm.

    By • Dec. 12, 2024
  • Cyber internet security and privacy concept. Database storage 3d illustration.
    Image attribution tooltip
    JuSun via Getty Images
    Image attribution tooltip

    Artivion says cybersecurity incident has disrupted order, shipping processes

    The heart device manufacturer has taken certain systems offline in response to the incident, which involved the acquisition and encryption of files.

    By • Dec. 11, 2024
  • A picture of black and white medical images of a heart on a computer screen.
    Image attribution tooltip
    Retrieved from Cleerly on December 06, 2024
    Image attribution tooltip

    Cleerly raises $106M to fund AI-driven heart disease tool

    The company has generated evidence that shows its system is better than experts at assessing vessel narrowing, plaque volume and composition.

    By • Dec. 6, 2024
  • An image of Edwards Lifesciences' Irvine, California, campus at dusk.
    Image attribution tooltip
    Courtesy of Edwards Lifesciences
    Image attribution tooltip

    Edwards expects new TAVR approval in mid-2025 to boost sales

    U.S. approval of an expanded indication for transcatheter aortic valve replacement in patients without symptoms is among the growth catalysts Edwards outlined in an investor day presentation.

    By • Dec. 5, 2024
  • Shot of three business persons filling in paperwork in an office.
    Image attribution tooltip
    Violeta Stoimenova via Getty Images
    Image attribution tooltip

    Haemonetics to offload whole-blood business for up to $67M

    Selling the assets to Italy’s GVS should help Haemonetics improve its revenue growth and profit margins, analysts said.

    By • Dec. 4, 2024
  • A large group of dosing pens for subcutaneous injection of anti-obesity medication piled in a heap.
    Image attribution tooltip
    aprott via Getty Images
    Image attribution tooltip

    Biden administration proposes Medicare, Medicaid coverage of pricey weight loss drugs

    About 7.4 million Americans with obesity could have insurance coverage for drugs like Wegovy if the Trump administration allows the rule to go into effect — at the cost of $40 billion to federal and state governments.

    By Rebecca Pifer • Nov. 27, 2024
  • The exterior of Medtronic's Minnesota operational headquarters is shown along with its reflection in a pool of water.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic’s ablation sales slowed by PFA supply issues

    CEO Geoff Martha said the business did not meet internal growth expectations last quarter due to third-party supply issues that have now been resolved.

    By • Nov. 19, 2024